Form 4: Medpace Director Acquires 113 Restricted Stock Units

Medpace Holdings, Inc. Director Cornelius P. McCarthy III was granted 113 restricted stock units, vesting quarterly through December 2026.

Summary

• Cornelius P. McCarthy III, a Director at Medpace Holdings, Inc. (MEDP), acquired 113 Restricted Stock Units (RSUs).
• Each RSU represents a contingent right to receive one share of MEDP common stock.
• The RSUs were granted on November 28, 2025, with an underlying value of $592.46 per unit.
• These RSUs will vest in four approximately equal installments on March 31, 2026, June 30, 2026, September 30, 2026, and December 31, 2026.
• Following this transaction, Mr. McCarthy beneficially owns 113 derivative securities (RSUs) and 10,246 shares of common stock directly.

Sentiment

Score: 7

Explanation: The grant of equity to a director is generally a positive signal, aligning interests and incentivizing long-term performance, though it's a routine compensation event rather than a major strategic announcement.

Positives

• The grant of Restricted Stock Units aligns the director's interests with long-term shareholder value through future equity vesting.
• The acquisition of additional equity by a director can signal confidence in the company's future performance.

Negatives

• No direct negatives are apparent from this specific Form 4 filing, which reports an equity grant.

Risks

• No specific risks related to the company's operations or financial health are mentioned in this Form 4 filing.

Future Outlook

The Restricted Stock Units granted to Director McCarthy are scheduled to vest in four equal quarterly installments throughout 2026, indicating a future equity stake contingent on continued service and company performance.

Industry Context

This RSU grant is a standard form of executive and director compensation in the life sciences and contract research organization (CRO) industry, aiming to retain key talent and align their long-term interests with company performance and shareholder returns.

Stakeholder Impact

• Shareholders: The grant of RSUs to a director aligns management's interests with shareholder value creation over the long term.
• Employees: No direct impact on general employees is indicated by this specific filing.

Next Steps

• The 113 Restricted Stock Units will vest in four approximately equal installments.
• First vesting installment on March 31, 2026.
• Second vesting installment on June 30, 2026.
• Third vesting installment on September 30, 2026.
• Fourth and final vesting installment on December 31, 2026.

Key Dates

Keywords

Medpace Holdings, MEDP, Form 4, Restricted Stock Units, RSU, Director Compensation, Insider Trading, Equity Grant, Cornelius P. McCarthy III